IL-15 is elevated in serum patients with type 1 diabetes mellitus

McInnes, 1998, Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis, Immunol. Today, 2, 75, 10.1016/S0167-5699(97)01205-X

Fehninger, 2001, Interleukin 15: biology and relevance to human disease, Blood, 97, 14, 10.1182/blood.V97.1.14

Carson, 1996, Interleukin 15: a potential player during the innate response to infection, Exp. Parasitol., 84, 291, 10.1006/expr.1996.0115

Rabinovitch, 1998, An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus, Diab. Metab. Rev., 14, 129, 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V

Winiarska, 1998, Lymphocyte subpopulations in type I diabetics treated with intensive insulin therapy, Pol. J. Pharmacol., 50, 251

Adeyemi, 2002, Interleukin 15 in healthy donors and patients with hepatitis virus C- positive chronic liver disease, AJG, 97, S88, 10.1016/S0002-9270(02)04741-X

Losy, 2002, IL-15 is eleveted in sera of patients with relapsing-remitting multiple sclerosis, Folia Neuropathol., 40, 151

Perera, 2000, Interleukin 15: its role in inflammation and immunity, Arch. Immunol. Ther. Exp., 48, 457

Dworacka, 2002, 1,5-Anhydro-d-glucitol: a novel marker of glucose excursions, Int. J. Clin. Pract., 129, 40

Yabuuchi, 1984, Simple enzymatic method for determining 1,5-anhydro-d-glucitol for diagnosis of diabetes mellitus, Clin. Chem., 35, 2039, 10.1093/clinchem/35.10.2039

Dworacka, 1997, The usefulness of 1,5-anhydro-d-glucitol estimation in plasma of patients with type 2 diabetes, Diagn. Lab., 33, 269

Schilchtkrul, 1965, The M-value an index of blood-sugar control diabetics, Acta Med. Scand., 177, 95, 10.1111/j.0954-6820.1965.tb01810.x

McDonald, 1998, Interleukin-15 (IL-15) induced NF-κB activation and IL-8 production un human neutrophilis, Blood, 12, 4828, 10.1182/blood.V92.12.4828

Zozulińska, 1999, Serum interleukin-8 level is increased in diabetic patients, Diabetologia, 42, 117, 10.1007/s001250051124

Kumaki, 1996, Interleukin-15 up-regulates interleukin-2 receptor α chain but down regulates its own highaity binding sites on human T and B cells, Euro. J. Immunol., 26, 1235, 10.1002/eji.1830260608

McInnes, 1997, Interleukin-15 mediates T-cell dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis, Nat. Med., 3, 189, 10.1038/nm0297-189

Porat, 1989, The effects of tumor necrosis factor-α on the activity of lipoprotein lipase in adipose tissue, Limphokine Res., 4, 459

Argiles, 1989, Interleukin-1 and lipid metabolism in the rat, Biochem. J., 256, 673, 10.1042/bj2590673

Shanmugam, 2003, High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells, Diabetes, 52, 1256, 10.2337/diabetes.52.5.1256

Yu, 2003, Influence of acute hyperglycaemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations, World J. Gastroenetrol., 8, 1824, 10.3748/wjg.v9.i8.1824

Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans. Role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE

Giordano, 1995, Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patients, Diabetologia, 8, 953, 10.1007/BF00400585

Bouchard, 2004, Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased actvity of caspase-3 and caspase-8, J. Leukoc. Biol., 75, 893, 10.1189/jlb.1103585